TerminatedPhase 4ketamine

Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy

Sponsored by Icahn School of Medicine at Mount Sinai

NCT ID
NCT02643979
Target Enrollment
22 participants
Start Date
2016-01-01
Est. Completion
2019-01-05

About This Study

Propofol is one of the most popular anesthetic drugs used for sedation during upper gastrointestinal endoscopies due to its quick onset and quick resolution of symptoms allowing patients to leave the hospital sooner. However, when administered it can also slow the breathing of patients and cause others to have upper airway obstruction (such as snoring) which can impede proper spontaneous breathing. Ketamine is an agent that is capable of providing both pain control and sedation while having either minimal effect on breathing or promoting spontaneous breathing. Combining Ketamine with Propofol has the potential to reduce the total amount of Propofol used resulting in a procedure being performed under the same level of sedation but without the downside of reduced spontaneous breathing. Patients who are obese (defined as body mass index greater than 35) tend to be even more susceptible to this effect of Propofol. The researchers are investigating whether the addition of Ketamine will indeed allow for this continued comfortable level of sedation while promoting continued spontaneous breathing in obese patients undergoing upper gastrointestinal endoscopies.

Conditions Studied

ObesityBariatricsSleep Apnea SyndromesGastric BypassEndoscopy

Interventions

  • Ketofol
  • Propofol
  • Saline

Eligibility

Age:18 Years - N/A
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* BMI \> 30
* Undergoing an upper gastrointestinal endoscopy

Exclusion Criteria:

* History of schizophrenia/schizoaffective disorder
* History of bipolar disorder
* History of dementia
* Non-English Speaking
* History of Glaucoma
* Craniofacial Abnormalities
* Epilepsy
* Allergy to Propofol
* Allergy to Ketamine
* Current known intracranial mass/lesion

Study Locations (1)

Icahn School of Medicine at Mount Sinai
New York, New York, United States

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source